Global Artificial Insemination Market
Artificial insemination is a medical process involving the deliberate introduction of sperm into a female mammalโs uterus for the purpose of impregnating or fertilizing her for sexual reproduction. It is primarily a fertility treatment process for humans, and is a usual practice for animal breeding. Recipients of artificial insemination include single mothers and infertile couples. Intrauterine Insemination (IUI) is the most widely operated method of artificial insemination. Increasing prevalence of reproductive infertility is an indispensable factor contributing to the growth of the global artificial insemination market. According to a research paper published in PLOS Medicine, in 2010, around 48.5 million couples worldwide were unable to conceive a child. These days, various home-use kits, including ovulation kits, pregnancy detection kits, and insemination devices, are available globally for couples.
๐๐จ ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐๐ซ๐ @ย https://www.coherentmarketinsights.com/insight/request-pdf/1793
Global Artificial Insemination Market Dynamics
Numerous pharmaceutical companies around the world have been actively developing new products like insemination kits, some of which are currently undergoing clinical and preclinical trials. This, in turn, is propelling the growth of the global artificial insemination market. For instance, a 2015 clinical trial of Stork OTC kit showed effectiveness at delivering higher concentrations of sperm to the cervix as compared to natural intercourse. The Stork OTC delivered an around three times higher value of sperm concentration to up to 85% of the subjects participating in the study, whereas, the remaining 15% showed no change in sperm concentration at the cervix. The device, which received an over-the-counter approval from the FDA in July 2014, provides a safe and simple way for users to deliver the sperm, avoiding an unfavorable vaginal environment.
As per the National Womenโs Health Resource Center, infertility impacts over 20 million women across the globe. In the 2017 United Nations World Population Prospects report, it was speculated that the total fertility rate would decrease from 2.43 to 2.39 (children per woman) between the years 2020 and 2030. Rising incidence of infertility is majorly boosting the global artificial insemination market expansion.
๐๐จ ๐๐๐ญ ๐ฆ๐จ๐ซ๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ โhttps://www.coherentmarketinsights.com/insight/request-sample/1793
However, stringent regulations regarding fertility treatments, which are being implemented across several countries, is a significant factor hampering the global market growth. For instance, Italy and France forbid single women from using artificial insemination devices. Moreover, Norway and Germany have strictly prohibited egg donations; however, sperm donations are allowed in these countries.
Global Artificial Insemination Market โ Regional Insights
The North America market holds the dominant position in the global artificial insemination market, owing to technological advancements and favorable rules and regulations in the region. For instance, according to 2018 National Conference of State Legislature report, 14 states have laws mandating that employers offer insurance for fertility treatment. Hawaii, Arkansas, Texas, and Maryland mandate coverage for in vitro fertilization only, excluding inseminations.
Furthermore, the Asia Pacific artificial insemination market is projected to witness significant growth owing to increasing prevalence of infertility among the populace and less stringent regulations. For instance, according to the United Nation Department of Economic and Social Affairs 2015 report shows a fertility rate decline from 1.3 to 1.4 children per woman.
๐ ๐จ๐ซ ๐๐จ๐ซ๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐จ๐ซ ๐๐ฎ๐๐ซ๐ฒ ๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ , ๐๐ข๐ฌ๐ข๐ญ ๐๐ญ โย https://www.coherentmarketinsights.com/insight/talk-to-analyst/1793
Global Artificial Insemination Market โ Competitive Landscape
The key players operating in the global artificial insemination market include Pride Angel, Irvine Scientific, Hi-Tech Solutions, Rinovum Womenโs Health, LLC, TenderNeeds Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pvt. Ltd. These players have been adopting various growth strategies, such as collaborations, acquisitions, and new product launches, to maintain their positions in the global market. For instance, in 2016, Worthington Industries, in collaboration with Intellectual Ventures, launched the innovative AIS 3 and AIS 1.5 artificial insemination shield refrigerators equipped with the advanced artificial insemination shield canisters for holding samples.
Market Taxonomy
On the basis of procedure type, the global artificial insemination market is segmented into:
โข Intrauterine Insemination
โข Intracervical Insemination
โข Intravaginal Insemination
โข Intratubal Insemination
Based on product type, the global artificial insemination market is bifurcated into:
โข Insemination Kits
โข Home Conception Devices
โข Accessories
The global artificial insemination market comprises various end users, such as:
โข Hospitals
โข Clinics
โข Fertility Centers
โข Others
The global artificial insemination market is geographically segmented into:
โข North America
โข Latin America
โข Europe
โข Asia Pacific
โข Middle East
โข Africa
๐๐จ ๐๐ข๐ซ๐๐๐ญ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ โhttps://www.coherentmarketinsights.com/insight/buy-now/1793
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
